aTyr Pharma   Report issue

For profit Phase 2
Founded: San Diego CA United States (2005)

Organization Overview

First Clinical Trial
2014
NCT02239224
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

aTyr Pharma, Inc.